Aim: Several recent studies have indicated that a number of salivary biomarkers seem to be compromised in smokers with periodontal disease. The aim of this study is to assess salivary levels of cyanide and thiocyanate in Syrian patients with chronic (ChP) and aggressive (AgP) periodontitis, and to investigate the effect of smoking on these two biomarkers.
INTRODUCTION
Saliva is an important biological fluid with clinically informative properties that can provide novel approaches in diagnosis, monitoring, and management of patients 1 Periodontal diseases are chronic inflammatory entities that are initiated by bacterial plaque deposited on the adjacent teeth and characterized by infiltration of leukocytes, loss of connective tissues and alveolar bone resorption. Periodontitis is a complex multifactorial disease that is affected by the interaction between bacteria, multiple genes, and environmental factors. Smoking is one of the most important risk factors for periodontitis. The effects of smoking manifest as greater attachment loss, deeper periodontal pockets and a significant increase in bone loss. Hence, periodontitis is more prevalent and severe among smokers. 2 Historically, clinical and radiographic measures of periodontal tissue destruction have been the main go-to means for diagnosis of periodontal disease. However, over the past few years, there has been increasing interest in the use of saliva for the diagnosis of oral and systemic diseases. 1 The tendency to use human saliva for diagnostic purposes has gained momentum due to its noninvasive nature and decreased infection risk as opposed to chemical analysis of blood and/or urine samples. 3 Numerous studies have investigated the composition, flow rate, PH, buffer capacity, ions, proteins and a number of other components in the salivary samples from patients with varying degrees of periodontitis. Consequently, based upon the finding of these studies certain salivary properties and constituents were suggested as possible biomarkers for diagnosing and monitoring periodontal diseases.
Cyanide is a highly toxic chemical and an essential reagent for many industrial processes. It occurs naturally in plant seeds as a cyanogenic glycoside. Furthermore, cyanide may also be present in drinking water, soil, and air. Human exposure to cyanide is also associated with tobacco smoking. 4 Prolonged exposure to cyanide leads to the weakening of the body, the occurrence of many diseases and even death. 5 Salivary thiocyanate (SCN), a metabolic product of cyanide, is a normal component of numerous body fluids such as saliva, tears, and serum. Its main sources in the human body are diet and tobacco. SCN is secreted in saliva and has a long half-life of 10-14 days in normal adults. 6 Normal nonsmokers have salivary SCN concentration in ranges from 0.5 to 2 mm. However, heavy smokers may have a salivary concentration that can reach up to 6 mm. SCN has been shown to be a chemical indicator in smokers and smokeless tobacco users. Measurement of CN and SCN are of growing importance in monitoring some clinical conditions and distinguishing tobacco smokers from nonsmokers and determining some clinical conditions. 7 Aggarwal et al. indicated a significant increase in SCN levels in saliva of cigarette smokers as compared to nonsmokers and suggested that salivary SCN can be used as a safe and acceptable prevalence measurement for cigarette smoking behavior. 8 A review of the literature revealed limited studies examining CN levels in saliva of patients with periodontitis. On the other hand, there are a handful of studies collating and associating the salivary levels of SCN in smokers with chronic periodontitis to other patient groups. 6 The aim of this study was to examine the salivary levels of cyanide and thiocyanate in patients with periodontitis (chronic and aggressive) and to investigate any possible association between smoking and these two salivary biomarkers.
MATERIALS AND METHODS

Study Population
The study was approved by the Institutional Ethics Committee at Damascus University.
Patients referred to the Department of Periodontology, Faculty of Dentistry, Damascus University were invited to participate in the study. In total, 162 subjects were enrolled in the study. Thorough medical and dental histories were obtained and a complete periodontal chart was recorded for each participant. Examined periodontal parameters included: plaque index (PI), gingival index (GI), and probing pocket depth (PPD). Panoramic dental tomographs were used to confirm the diagnosis.
Subjects were excluded if they met any of these conditions: had less than 20 teeth (other than third molars), had any systemic disease, underwent treatment with antibiotics over the past three months, pregnancy, breastfeeding and had any diseases or conditions that affect the secretion of saliva.
Finally, all participants gave their written consent after being informed about the nature of the study and its purpose.
Participants were categorized into four groups according to the guidelines of the American Academy of Periodontology 1999: years; mean age 27 years) and had healthy periodontium and were matching to group AgP. Subjects in all study groups were categorized as smokers if they had > 5 cigarettes per day for the past 3 years.
Collection of Samples
Subjects were asked to refrain from drinking (except water), food intake, chewing gum and tooth brushing within 2 hours of sampling. All saliva samples were collected at appointments between 11 am and 12 noon. Whole unstimulated saliva was collected by spitting without swallowing with the subject seated in an upright position. Sterilized plastic tubes containing the collected saliva were stored at -20º until future use.
Laboratory Studies
Cyanide Determination
Spectrophotometric determination of cyanide was performed according to the method described by Pitschmann et al. 9 In brief, a tube was filled with measured 2 mL of a standard solution with added 0.2 mL of sodium hydroxide solution, 2 mL of p-nitrobenzaldehyde solution, 2 mL of tetrazolium blue solution, and completed by 10 mL of methanol. After 30 minutes, the formed red-purple color was measured at a wavelength of 520 nm as opposed to methanol.
The values for creating a calibration graph were acquired by measuring a series of standard working solutions of cyanides in different concentrations. Values measured in blind determinations with distilled water were subtracted from values measured in the individual standards. Statistical evaluation of the method was carried out in the usual way; the concentration of cyanides in the formulas was determined directly from the calibration graph, with regard to the dilution or by the Lambert-Beer law.
Thiocyanate Determination
The procedures to determine thiocyanate levels were conducted according to the method described by Lahti et al. 10 Briefly, after centrifugation, a 0.5 mL of supernatant saliva was mixed with 9.5 mL Fe (NO 3 ) 3 Table 1 shows the main characteristics of the study population. In this study, a total of 162 subjects were recruited. There were 21 (47.7%) smokers and 23 (52.3%) nonsmokers in ChP group. Whilst group EC had 16 (40%) smokers and 24 (60%) nonsmokers. Likewise, There were 13 (47.7%) smokers and 23 (52.3) nonsmokers in AgP group compared to 24 (52.2%) smokers and 22(47.8%) nonsmokers in YC group (Table 1) .
RESULTS
The mean GI, PI, and BOP are presented in Table 2 . In general, higher measurement values of the examined clinical parameters were recorded in both disease groups as opposed to the corresponding control groups, especially among smokers ( Table 2) .
The mean salivary levels of CN and SCN are presented in Table 3 . The mean CN level from patients with ChP was 1.59 mg/L compared to 1.018 mg/L in EC group. This difference was highly significant (p <0.001). Similarly, there was a significant difference (p = 0.03) in the mean level of CN in patients with AgP compared to subjects in YC group (Table 3 ).
Similarly, the mean level of SCN was 141.5 mg/L and 90.52 mg/L in ChP and EC groups respectively. This difference was highly significant (p <0.001). Likewise, SCN was significantly higher in AgP group (102.4 mg/L) as opposed to the corresponding YC controls (85.5 mg/L) ( Table 3) .
As can be seen in Table 4 , the Spearman correlation test revealed highly significant correlation (p <0.001) between salivary levels of CN and SCN and both PI and GI indices among patients with AgP. However, there was no significant correlation between CN and SCN salivary levels and PI, GI and BOP indices in ChP group (Table 4) .
The data from Table 5 show that smoking patients from AgP and ChP groups had a highly significant (p <0.001) salivary levels of CN and SCN as opposed to the corresponding control groups and nonsmokers (Table 5 ). 
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DISCUSSION
Over the past decade, saliva has gained increasing interest as compared to other biological fluids such as blood and urine. Assessment of saliva composition and properties has been used to better understand variations in oral diseases. In this regard examination of saliva has become a contributory aid in the assessment of risk factors and the evaluation of disease progression and would constitute an important tool in the clinical diagnosis of active periodontitis.
To the best of our knowledge, this study is the first report that attempted to analyze salivary CN levels in patients with ChP and AgP. Moreover, the present study is the first report to assess salivary SCN levels among patients with AgP as well as comparing its correlation with smoking.
The present study showed significantly higher levels (p < 001) of salivary CN and SCN in patients with ChP and AgP compared to periodontally healthy subjects. Furthermore, CN and SCN levels were significantly higher (p < 0.05) in smokers when compared to nonsmokers among patients in both ChP and AgP groups. These findings were in line with results of previous studies. Data obtained from the study of Kalburgi et al. exhibited a significant increase in salivary SCN among smokers and gutka chewers with ChP as compared to healthy and nonsmokers with ChP. 11 Similarly, Hedge et al. reported a significant increase in SCN salivary levels in smokers with ChP as compared to nonsmokers. 12 The notoriety of cyanide has been known to mankind since antiquity. Cyanide is a mitochondrial toxin that impairs cellular respiration, causing morbidity or mortality within a short time. Cyanide's actions are complex and cannot be attributed solely to the deprivation of cellular oxygen. Recent mechanistic studies show that cyanide inhibits multiple enzymes and alters several vital intracellular processes that lead to a cascade of toxic events. 13 CN has fast absorption and distribution into tissues and the bloodstream, binding to metalloenzymes and rendering them inactive. A small amount of cyanide intake occurs during the process of smoking tobacco. Consequently, cyanide and thiocyanate concentrations in the plasma, whole blood, saliva, and tissues of such smokers are elevated relative to non-smokers. in certain settings, chronic cyanide exposure through inhalation of tobacco cigarette smoke has been associated with the disease. 14 Cyanide has been previously shown to induce oxidative stress and damage in a number of biological systems. Cyanide-induced oxidative stress may be due to increases in reactive oxygen species (ROS) and nitric oxide as well as to inhibition of antioxidant system and mitochondrial function. There are numerous evidence that oxidative stress has been implicated in diverse pathological conditions. It has been revealed that ChP has been associated with lower levels of total antioxidant capacity and oxidative stress has been considered a strong feature in periodontitis. Also, salivary peroxidase plays dual role acting as both an antibacterial and as antioxidant vector. This enzyme is of great importance in the oral defense mechanism especially against the attack of ROS. However, in smokers, it has a decreased activity due to the cyanide ions present in cigarette smoke. 16 On another note, this study demonstrated a negative correlation between GI and BOP parameters in smokers with AgP and ChP and salivary levels of CN and SCN. This finding is in agreement with the findings of a number of recent studies which have reported that salivary SCN levels are in an inverse relationship with gingival inflammation and plaque. 11 The result of our study can be attributed to the detrimental effects of smoking on humans. Smoking has been identified as a major environmental risk factor associated with increased incidence and severity of periodontitis. 17 Tobacco use leads to a change in the production or composition of saliva along with an alteration in the mucosal permeability and can predispose to oral cancer. Additionally, there is higher periodontal pocket depth and loss of attachment in smokers. Nevertheless, it is noticed that nicotine causes vasoconstriction of gingival blood vessels leading to less bleeding on probing in smokers. Hence, the compromised salivary system makes the periodontium more susceptible to the disease process and the clinical symptoms continue to occur at a slower rate. 18 Ideally, the immune system should be capable of reducing the harmful bacteria in the mouth that cause periodontal disease. However, the chemicals in tobacco, including carbon monoxide, nicotine, tar, and cyanide not only increase the accumulation of plaque and calculus that can irritate the gingiva and cause infection but also affect the immune system, reducing the ability to fight off these pathogens and heal the damaged periodontium properly.
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Limitations of the Study
It is noteworthy to mention that the main shortcoming of this study was related to making a direct comparison to previous work on the investigated subject. This task was not an as smooth process as one might expect due to the lack of similar studies in the literature especially the ones examining the levels of CN in the saliva of patients with ChP and AgP.
CONCLUSION
Based upon the results obtained of this study, it can be concluded that patients who were smokers with chronic and aggressive periodontitis have significantly increased levels of salivary cyanide and thiocyanate as compared to nonsmokers. Thus, it is suggested that salivary CN and SCN can be considered a useful reliable biomarker that can help in following patients with periodontitis.
